Corticosteroid Injections for Joint Pain Market Insights, Global Outlook and Forecast 2022-2028
Corticosteroid Injections for Joint Pain Market Insights, Global Outlook and Forecast 2022-2028
Discover the latest insights into the booming Corticosteroid Injections for Joint Pain Market. This report analyzes market size, growth trends (CAGR ), key players, and regional performance, offering valuable data for investors and industry professionals. Explore market drivers, restraints, and future projections for -.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
Corticosteroid Injections products used for Joint Pain.
The latest research study released by Market IntelliX evaluates market size and forecasts of Corticosteroid Injections for Joint Pain in global, including the following market information:
Global Corticosteroid Injections for Joint Pain Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Corticosteroid Injections for Joint Pain Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Corticosteroid Injections for Joint Pain companies in 2021 (%)
The global Corticosteroid Injections for Joint Pain market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Knee & Ankle Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Corticosteroid Injections for Joint Pain include Allergan, Pfizer, Sanofi, Anika Therapeutics, Ferring, Bioventus, Flexion Therapeutics, Zimmer Biomet and SEIKAGAKU and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MI has surveyed the Corticosteroid Injections for Joint Pain manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Market Segmentations:
Global Corticosteroid Injections for Joint Pain Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Corticosteroid Injections for Joint Pain Market Segment Percentages, by Type, 2021 (%)
Knee & Ankle
Hip Joint
Shoulder & Elbow
Facet Joints of the Spine
Others
Global Corticosteroid Injections for Joint Pain Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Corticosteroid Injections for Joint Pain Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Corticosteroid Injections for Joint Pain Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Corticosteroid Injections for Joint Pain Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Corticosteroid Injections for Joint Pain revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Corticosteroid Injections for Joint Pain revenues share in global market, 2021 (%)
Key companies Corticosteroid Injections for Joint Pain sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Corticosteroid Injections for Joint Pain sales share in global market, 2021 (%)
The report presents profiles of competitors in the market, Some of the prominent key players covered:
Allergan
Pfizer
Sanofi
Anika Therapeutics
Ferring
Bioventus
Flexion Therapeutics
Zimmer Biomet
SEIKAGAKU
Chugai Pharma
Key Takeaways from this Report
Evaluate market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level – for product types, end use applications and by different industry verticals.
Understand the different dynamics influencing the market – key driving factors, challenges and hidden opportunities.
Get in-depth insights on your competitor performance – market shares, strategies, financial benchmarking, product benchmarking, SWOT and more.
Analyze the sales and distribution channels across key geographies to improve top-line revenues.
Understand the industry supply chain with a deep-dive on the value augmentation at each step, in order to optimize value and bring efficiencies in your processes.
Get a quick outlook on the market entropy – M&A’s, deals, partnerships, product launches of all key players for the past 4 years.
Evaluate the supply-demand gaps, import-export statistics and regulatory landscape for more than top 20 countries globally for the market.
1 Introduction to Research & Analysis Reports
1.1 Corticosteroid Injections for Joint Pain Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Corticosteroid Injections for Joint Pain Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Corticosteroid Injections for Joint Pain Overall Market Size
2.1 Global Corticosteroid Injections for Joint Pain Market Size: 2021 VS 2028
2.2 Global Corticosteroid Injections for Joint Pain Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Corticosteroid Injections for Joint Pain Sales: 2017-2028
3 Company Landscape
3.1 Top Corticosteroid Injections for Joint Pain Players in Global Market
3.2 Top Global Corticosteroid Injections for Joint Pain Companies Ranked by Revenue
3.3 Global Corticosteroid Injections for Joint Pain Revenue by Companies
3.4 Global Corticosteroid Injections for Joint Pain Sales by Companies
3.5 Global Corticosteroid Injections for Joint Pain Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Corticosteroid Injections for Joint Pain Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Corticosteroid Injections for Joint Pain Product Type
3.8 Tier 1, Tier 2 and Tier 3 Corticosteroid Injections for Joint Pain Players in Global Market
3.8.1 List of Global Tier 1 Corticosteroid Injections for Joint Pain Companies
3.8.2 List of Global Tier 2 and Tier 3 Corticosteroid Injections for Joint Pain Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Corticosteroid Injections for Joint Pain Market Size Markets, 2021 & 2028
4.1.2 Knee & Ankle
4.1.3 Hip Joint
4.1.4 Shoulder & Elbow
4.1.5 Facet Joints of the Spine
4.1.6 Others
4.2 By Type - Global Corticosteroid Injections for Joint Pain Revenue & Forecasts
4.2.1 By Type - Global Corticosteroid Injections for Joint Pain Revenue, 2017-2022
4.2.2 By Type - Global Corticosteroid Injections for Joint Pain Revenue, 2023-2028
4.2.3 By Type - Global Corticosteroid Injections for Joint Pain Revenue Market Share, 2017-2028
4.3 By Type - Global Corticosteroid Injections for Joint Pain Sales & Forecasts
4.3.1 By Type - Global Corticosteroid Injections for Joint Pain Sales, 2017-2022
4.3.2 By Type - Global Corticosteroid Injections for Joint Pain Sales, 2023-2028
4.3.3 By Type - Global Corticosteroid Injections for Joint Pain Sales Market Share, 2017-2028
4.4 By Type - Global Corticosteroid Injections for Joint Pain Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Corticosteroid Injections for Joint Pain Market Size, 2021 & 2028
5.1.2 Hospital Pharmacies
5.1.3 Retail Pharmacies
5.1.4 Online Pharmacies
5.2 By Application - Global Corticosteroid Injections for Joint Pain Revenue & Forecasts
5.2.1 By Application - Global Corticosteroid Injections for Joint Pain Revenue, 2017-2022
5.2.2 By Application - Global Corticosteroid Injections for Joint Pain Revenue, 2023-2028
5.2.3 By Application - Global Corticosteroid Injections for Joint Pain Revenue Market Share, 2017-2028
5.3 By Application - Global Corticosteroid Injections for Joint Pain Sales & Forecasts
5.3.1 By Application - Global Corticosteroid Injections for Joint Pain Sales, 2017-2022
5.3.2 By Application - Global Corticosteroid Injections for Joint Pain Sales, 2023-2028
5.3.3 By Application - Global Corticosteroid Injections for Joint Pain Sales Market Share, 2017-2028
5.4 By Application - Global Corticosteroid Injections for Joint Pain Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Corticosteroid Injections for Joint Pain Market Size, 2021 & 2028
6.2 By Region - Global Corticosteroid Injections for Joint Pain Revenue & Forecasts
6.2.1 By Region - Global Corticosteroid Injections for Joint Pain Revenue, 2017-2022
6.2.2 By Region - Global Corticosteroid Injections for Joint Pain Revenue, 2023-2028
6.2.3 By Region - Global Corticosteroid Injections for Joint Pain Revenue Market Share, 2017-2028
6.3 By Region - Global Corticosteroid Injections for Joint Pain Sales & Forecasts
6.3.1 By Region - Global Corticosteroid Injections for Joint Pain Sales, 2017-2022
6.3.2 By Region - Global Corticosteroid Injections for Joint Pain Sales, 2023-2028
6.3.3 By Region - Global Corticosteroid Injections for Joint Pain Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Corticosteroid Injections for Joint Pain Revenue, 2017-2028
6.4.2 By Country - North America Corticosteroid Injections for Joint Pain Sales, 2017-2028
6.4.3 US Corticosteroid Injections for Joint Pain Market Size, 2017-2028
6.4.4 Canada Corticosteroid Injections for Joint Pain Market Size, 2017-2028
6.4.5 Mexico Corticosteroid Injections for Joint Pain Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Corticosteroid Injections for Joint Pain Revenue, 2017-2028
6.5.2 By Country - Europe Corticosteroid Injections for Joint Pain Sales, 2017-2028
6.5.3 Germany Corticosteroid Injections for Joint Pain Market Size, 2017-2028
6.5.4 France Corticosteroid Injections for Joint Pain Market Size, 2017-2028
6.5.5 U.K. Corticosteroid Injections for Joint Pain Market Size, 2017-2028
6.5.6 Italy Corticosteroid Injections for Joint Pain Market Size, 2017-2028
6.5.7 Russia Corticosteroid Injections for Joint Pain Market Size, 2017-2028
6.5.8 Nordic Countries Corticosteroid Injections for Joint Pain Market Size, 2017-2028
6.5.9 Benelux Corticosteroid Injections for Joint Pain Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Corticosteroid Injections for Joint Pain Revenue, 2017-2028
6.6.2 By Region - Asia Corticosteroid Injections for Joint Pain Sales, 2017-2028
6.6.3 China Corticosteroid Injections for Joint Pain Market Size, 2017-2028
6.6.4 Japan Corticosteroid Injections for Joint Pain Market Size, 2017-2028
6.6.5 South Korea Corticosteroid Injections for Joint Pain Market Size, 2017-2028
6.6.6 Southeast Asia Corticosteroid Injections for Joint Pain Market Size, 2017-2028
6.6.7 India Corticosteroid Injections for Joint Pain Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Corticosteroid Injections for Joint Pain Revenue, 2017-2028
6.7.2 By Country - South America Corticosteroid Injections for Joint Pain Sales, 2017-2028
6.7.3 Brazil Corticosteroid Injections for Joint Pain Market Size, 2017-2028
6.7.4 Argentina Corticosteroid Injections for Joint Pain Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Corticosteroid Injections for Joint Pain Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Corticosteroid Injections for Joint Pain Sales, 2017-2028
6.8.3 Turkey Corticosteroid Injections for Joint Pain Market Size, 2017-2028
6.8.4 Israel Corticosteroid Injections for Joint Pain Market Size, 2017-2028
6.8.5 Saudi Arabia Corticosteroid Injections for Joint Pain Market Size, 2017-2028
6.8.6 UAE Corticosteroid Injections for Joint Pain Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Allergan
7.1.1 Allergan Corporate Summary
7.1.2 Allergan Business Overview
7.1.3 Allergan Corticosteroid Injections for Joint Pain Major Product Offerings
7.1.4 Allergan Corticosteroid Injections for Joint Pain Sales and Revenue in Global (2017-2022)
7.1.5 Allergan Key News
7.2 Pfizer
7.2.1 Pfizer Corporate Summary
7.2.2 Pfizer Business Overview
7.2.3 Pfizer Corticosteroid Injections for Joint Pain Major Product Offerings
7.2.4 Pfizer Corticosteroid Injections for Joint Pain Sales and Revenue in Global (2017-2022)
7.2.5 Pfizer Key News
7.3 Sanofi
7.3.1 Sanofi Corporate Summary
7.3.2 Sanofi Business Overview
7.3.3 Sanofi Corticosteroid Injections for Joint Pain Major Product Offerings
7.3.4 Sanofi Corticosteroid Injections for Joint Pain Sales and Revenue in Global (2017-2022)
7.3.5 Sanofi Key News
7.4 Anika Therapeutics
7.4.1 Anika Therapeutics Corporate Summary
7.4.2 Anika Therapeutics Business Overview
7.4.3 Anika Therapeutics Corticosteroid Injections for Joint Pain Major Product Offerings
7.4.4 Anika Therapeutics Corticosteroid Injections for Joint Pain Sales and Revenue in Global (2017-2022)
7.4.5 Anika Therapeutics Key News
7.5 Ferring
7.5.1 Ferring Corporate Summary
7.5.2 Ferring Business Overview
7.5.3 Ferring Corticosteroid Injections for Joint Pain Major Product Offerings
7.5.4 Ferring Corticosteroid Injections for Joint Pain Sales and Revenue in Global (2017-2022)
7.5.5 Ferring Key News
7.6 Bioventus
7.6.1 Bioventus Corporate Summary
7.6.2 Bioventus Business Overview
7.6.3 Bioventus Corticosteroid Injections for Joint Pain Major Product Offerings
7.6.4 Bioventus Corticosteroid Injections for Joint Pain Sales and Revenue in Global (2017-2022)
7.6.5 Bioventus Key News
7.7 Flexion Therapeutics
7.7.1 Flexion Therapeutics Corporate Summary
7.7.2 Flexion Therapeutics Business Overview
7.7.3 Flexion Therapeutics Corticosteroid Injections for Joint Pain Major Product Offerings
7.7.4 Flexion Therapeutics Corticosteroid Injections for Joint Pain Sales and Revenue in Global (2017-2022)
7.7.5 Flexion Therapeutics Key News
7.8 Zimmer Biomet
7.8.1 Zimmer Biomet Corporate Summary
7.8.2 Zimmer Biomet Business Overview
7.8.3 Zimmer Biomet Corticosteroid Injections for Joint Pain Major Product Offerings
7.8.4 Zimmer Biomet Corticosteroid Injections for Joint Pain Sales and Revenue in Global (2017-2022)
7.8.5 Zimmer Biomet Key News
7.9 SEIKAGAKU
7.9.1 SEIKAGAKU Corporate Summary
7.9.2 SEIKAGAKU Business Overview
7.9.3 SEIKAGAKU Corticosteroid Injections for Joint Pain Major Product Offerings
7.9.4 SEIKAGAKU Corticosteroid Injections for Joint Pain Sales and Revenue in Global (2017-2022)
7.9.5 SEIKAGAKU Key News
7.10 Chugai Pharma
7.10.1 Chugai Pharma Corporate Summary
7.10.2 Chugai Pharma Business Overview
7.10.3 Chugai Pharma Corticosteroid Injections for Joint Pain Major Product Offerings
7.10.4 Chugai Pharma Corticosteroid Injections for Joint Pain Sales and Revenue in Global (2017-2022)
7.10.5 Chugai Pharma Key News
8 Global Corticosteroid Injections for Joint Pain Production Capacity, Analysis
8.1 Global Corticosteroid Injections for Joint Pain Production Capacity, 2017-2028
8.2 Corticosteroid Injections for Joint Pain Production Capacity of Key Manufacturers in Global Market
8.3 Global Corticosteroid Injections for Joint Pain Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Corticosteroid Injections for Joint Pain Supply Chain Analysis
10.1 Corticosteroid Injections for Joint Pain Industry Value Chain
10.2 Corticosteroid Injections for Joint Pain Upstream Market
10.3 Corticosteroid Injections for Joint Pain Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Corticosteroid Injections for Joint Pain Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
Research Methodology:
Corticosteroid Injections for Joint Pain Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|